Calls it a 'resounding defeat' for pesticide industry which has been promoting this deadly toxin
The numbers of people affected by nearly 20 years of aerial spray of Endosulfan, an organochlorine pesticide, in the cashew plantations in Kasaragod, the northern most district of Kerala is increasing. While the focus earlier was on Padre village, the health impacts are evident in people of nearly 11 panchayats in the district. Victims here are suffering from congenital deformities, physical disabilities, mental retardation and gynecological problems. The same health impacts are now being seen in the neighboring Dakshin Kanada district in Karnataka as well.
Pesticide industry body loses defamation case against CSE, twice
At the sixth meeting of Persistent Organic Pollutants Review Committee (POPRC) to the Stockholm Convention (Geneva Oct 11-15), India once again opposed a global ban on the manufacture, use, import and export of endosulfan. Of the 29 members in the review committee, 24 supported the ban and four (Germany, Ghana, Nigeria and China) abstained.
The Union environment ministry has proposed a five member expert committee to study the ill-effects of endosulfan. Union minister of state for environment, Jairam Ramesh, announced the panel after meeting Kerala forest minister Benoy Viswam on November 1.
The Endosulfan Manufactures and Formulators Welfare Association (EMFWA) have challenged the Karnataka ban on endosulfan in the Karnataka High Court. They pesticide manufacturers have said that the ban was 'unscientific' as there are no studies done in the state to prove that endosulfan was the cause of the health conditions of the people in the affected villages.
1. The recent ban on endosulfan in US
As the demand for a ban on Endosulfan in India is gaining pitch and Karnataka being the latest state to ban the pesticide, the Pesticide Manufacturers and Formulators Association of India (PMFAI) is going around crying foul. They are leaving no stone unturned to save endosulfan. Press meets across the country and plugged newspaper reports maligning studies that have indicted endosulfan in the past is a desperate attempt to save a US $100 million endosulfan industry.